［1］胡亚美，江载芳.幼年类风湿性关节炎［M］.诸福棠实用儿科学，第7版.2002，667.
［2］Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafstron I, et al. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduce joint destruction and increases the remission rate: a two-year randomized trial［J］. Arthritis Rheum, 2005, 52 (11):3360-3370.
［3］Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, Jacobs J,et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens:current questions and tentative answers in rheumatology［J］. Ann Rheum Dis, 2002, 61(8):718-722.
［4］Bechtold S, Ripperger P, Bonfig W, Pozza RD, Haefner R, Schwarz HP. Growth hormone changes bone geometry and body composition in patients with juvenile idiopathic arthritis requiring glucocorticoid treatment:A controlled study using peripheral quantitative computed tomography［J］.J Clin Endocrinol Metab, 2005, 90(6):3168-3173.
［5］闵月，徐琴英，王丽峰，宋晓翔，倪征，程江，等.全身性幼年特发性关节炎40例［J］.实用儿科临床杂志，2005,20(11):1082-1084.
［6］Boivin MA, Ye D, Kennedy JC, Al-Sadi R, Shepela C, Ma TY. Mechanism of glucocor ticoid regulation of the intestinal tight junction barrier［J］. Am J Physiol Gastrointest Liver Physiol, 2007, 292(2):590-598.
［7］Dayyani F, Belge KU, Frankenberger M, Mack M, Berki T, Ziegler-Heitbrock L. Mechanism of glucocorticoid-induced depletion of human CD14+CD16+ monocytes［J］. J  Leukoc Biol, 2003, 74(1):33-39.
［8］Batthish M, Schneider R, Ramanan AV, Achonu C, Young NL, Feldman BM. What does "active disease" mean? patient and parent perceptions of disease activity in the systemic arthritis form of juvenile idiopathic arthritis (SO-JIA)［J］.Rheumatology, 2005, 44(6):796-799.
［9］Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafstrom I. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate:a two-year randomized trial［J］. Arthritis Rheum, 2005, 52(11):3360-3370.
［10］Wassenberg S, Rau R, Steinfeld P, Zeidler H. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years:a multicenter, double-blind, placebo-controlled trial［J］. Arthritis Rheum, 2005, 52(11):3371-3380.
［11］Sanmartí R, Gómez-Centeno A, Ercilla G, Larrosa M, Vi¨nas O, Vazquez I, et al.  Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids［J］. Clin Rheumatol, 2007, 26(7):1111-1118.
［12］Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial［J］. Arthritis Rheum, 2005, 52(11):3381-3390.
［13］Jacobs JW, Geenen R, Evers AW, van Jaarsveld CH, Kraaimaat FW, Bijlsma JW. Short term effects of corticosteroid pulse treatment on disease activity and the wellbeing of patients with active rheumatoid arthritis［J］. Ann Rheum Dis, 2001, 60(1):61-64.
［14］薛海燕，曹兰芳，马敏，卢燕鸣， 毛海英， 顾越英. 激素治疗难治性全身型幼年特发性关节炎39例［J］. 实用儿科临床杂志, 2007, 22(9):678-679.
［15］周纬，殷蕾，杨珍. 幼年特发性关节炎28例诊断治疗分析［J］.中国实用儿科杂志，2003,18(2),99-100.
［16］姜红堃，孙桂莲，罗钢，姜红, 张乾忠. 46例幼年特发性关节炎的回顾性分析［J］. 中国医科大学学报, 2006, 35(3):322.
［17］Beukelman T, Arabshahi B, Cahill AM, Kaye RD, Cron RQ. Benefit of intraarticular corticosteroid injection under fluoroscopic guidance for subtalar arthritis in juvenile idiopathic arthritis［J］. J Rheumatol, 2006, 33(11):2330-2336.
［18］Cahill AM, Cho SS, Baskin KM, Beukelman T, Cron RQ, Kaye RD, et al. Benefit of fluoroscopically guided intraarticular, long-acting corticosteroid injection for subtalar arthritis in juvenile idiopathic arthritis［J］. Pediatr Radiol, 2007, 37(6):544-548.
［19］Marti P, Molinari L, Bolt IB, Seger R, Saurenmann RK. Factors Influencing the efficacy of intra-articular steroid injections in patients with juvenile idiopathic arthritis［J］. Eur J Pediatr, 2008, 167(4):425-430.
［20］Neidel J. Intra-articular steroid therapy for inflammatory rheumatic diseases in children and adolescents［J］. Orthopade, 2002, 31(12):1175-1178.
［21］Cleary AG, Murphy HD, Davidson JE. Intra-articular corticosteroid injections in juvenile idiopathic arthritis［J］. Arch Dis Child, 2003, 88 (3): 192-196.
［22］Souza L, Machado SH, Bredemeier M, Brenol JC, Xavier RM. Effect of inflammatory activity and glucocorticoid ［corrected］ use on nutritional variables in patients with juvenile idiopathic arthritis［J］. J Rheumatol, 2006, 33(3):601-608.
［23］Simon D, Lucidarme N, Prieur AM, Ruiz JC, Czernichow P. Linear growth in children suffering from juvenile idiopathic arthritis requiring steroid therapy:natural history and effects of growth hormone treatment on linear growth［J］. J Pediatr Endocrinol Metab, 2001, 14(6): 1483-1486.
［24］Simon D, Prieur AM, Quartier P, Charles RJ, Czernichow P. Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study［J］. J Clin Endocrinol Metab, 2007, 92(7): 2567-2573.
［25］Riddle R, Ryser CN, Morton AA, Sampson JD, Browne RH, Punaro MG, et al. The impact on health-related quality of life from non-steroidal anti-inflammatory drugs, methotrexate, or steroids in treatment for juvenile idiopathic arthritis［J］. J Pediatr Psychol, 2006, 31(3): 262-271.
［26］赵喻，曹兰芳. 幼年型类风湿关节炎诊治进展［J］.中国当代儿科杂志，2003，5（2）：180-183.
［27］卢燕鸣, 曹兰芳，陆伟容. 幼年型类风湿关节炎患者RDW及MCV的分析［J］.中国当代儿科杂志，2003，5（6）：548-549.
［28］曹兰芳，卢燕鸣，马敏，薛海燕，赵瑜，余汉卿，等. 幼年类风湿关节炎患儿血清白介素15变化与TH细胞亚群表达的研究［J］. 中国当代儿科杂志，2006，8（1）：9-12.